The Valley Desk

NCT05071716 · Interventional trial

Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis

Overall registry status Completed

Phase 3

Conditions Hepatic Encephalopathy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov